The central role of mitochondria in axonal degeneration in multiple sclerosis

Multiple Sclerosis Journal

Volumn 20, Issue 14, 2014, Pages 1806-1813

  Campbell, Graham R ^a   Worrall, Joseph T ^a   Mahad, Don J ^a  

^a UNIVERSITY OF EDINBURGH   (United Kingdom)

Author keywords

axon; Mitochondria; neurodegeneration and multiple sclerosis; neuron

Indexed keywords

ADENOSINE TRIPHOSPHATE; LACTIC ACID;

DISORDERS OF MITOCHONDRIAL FUNCTIONS; ENERGY METABOLISM; GRAY MATTER; HUMAN; MITOCHONDRION; MULTIPLE SCLEROSIS; MYELINATED NERVE; NERVE CELL; NERVE FIBER DEGENERATION; NONHUMAN; OLIGODENDROGLIA; REVIEW; AXON; AXONAL INJURY; AXOPLASM; CELL DISRUPTION; CELL FUNCTION; CELL METABOLISM; DEMYELINATION; DISEASE COURSE; INFLAMMATION; MYELINATION; NEUROPATHOLOGY; PERIKARYON; WHITE MATTER; METABOLISM; NERVE FIBER;

AXONS; GRAY MATTER; HUMANS; MITOCHONDRIA; MULTIPLE SCLEROSIS; MULTIPLE SCLEROSIS, CHRONIC PROGRESSIVE; NEURONS;

EID: 84924760978     PISSN: 13524585     EISSN: 14770970     Source Type: Journal    
DOI: 10.1177/1352458514544537     Document Type: Review

References (51)

1. Bø L, Vedeler CA, Nyland HI, et al. Subpial demyelination in the cerebral cortex of multiple sclerosis patients. J Neuropathol Exp Neurol. 2003 ; 62: 723-732
2. Cifelli A, Arridge M, Jezzard P, et al. Thalamic neurodegeneration in multiple sclerosis. Ann Neurol. 2002 ; 52: 650-653
3. Dutta R, Trapp BD.. Pathogenesis of axonal and neuronal damage in multiple sclerosis. Neurology. 2007 ; 68: S22 S43 - S31 S54
4. Stadelmann C, Wegner C, Brück W.. Inflammation, demyelination, and degeneration - recent insights from MS pathology. Biochim Biophys Acta. 2011 ; 1812: 275-282
5. McAlpine's multiple sclerosis. 3 rd ed.London: Churchill Livingston. 1998, p.592. Compston A, ed. London: Churchill Livingston ; 1998: 592.
6. Fisher E, Lee JC, Nakamura K, et al. Gray matter atrophy in multiple sclerosis: A longitudinal study. Ann Neurology. 2008 ; 64: 255-265
7. Tsutsui S, Stys PK.. Metabolic injury to axons and myelin. Exp Neurol. 2013 ; 246: 26-34
8. Waxman SG.. Ions, energy and axonal injury: Towards a molecular neurology of multiple sclerosis. Trends Mol Med. 2006 ; 12: 192-195
9. Ferguson B, Matyszak MK, Esiri MM, et al. Axonal damage in acute multiple sclerosis lesions. Brain. 1997 ; 120: 393-399
10. Kuhlmann T, Lingfeld G, Bitsch A, et al. Acute axonal damage in multiple sclerosis is most extensive in early disease stages and decreases over time. Brain. 2002 ; 125: 2202-2212
11. Trapp BD, Peterson J, Ransohoff RM, et al. Axonal transection in the lesions of multiple sclerosis. N Engl J Med. 1998 ; 338: 278-285
12. Henderson AP, Barnett MH, Parratt JD, et al. Multiple sclerosis: Distribution of inflammatory cells in newly forming lesions. Ann Neurol. 2009 ; 66: 739-753
13. Lucchinetti C, Brück W, Parisi J, et al. Heterogeneity of multiple sclerosis lesions: Implications for the pathogenesis of demyelination. Ann Neurol. 2000 ; 47: 707-717
14. Huizinga R, Linington C, Amor S.. Resistance is futile: Antineuronal autoimmunity in multiple sclerosis. Trends Immunol. 2008 ; 29: 54-60
15. Neumann H, Medana IM, Bauer J, et al. Cytotoxic T lymphocytes in autoimmune and degenerative CNS diseases. Trends Neurosci. 2002 ; 25: 313-319
16. Compston A, Coles A.. Multiple sclerosis. Lancet. 2008 ; 372: 1502-1517
17. Hauser SL, Chan JR, Oksenberg JR.. Multiple sclerosis: Prospects and promise. Ann Neurol. 2013 ; 74: 317-327
18. Peterson JW, Bö L, Mörk S, et al. Transected neurites, apoptotic neurons, and reduced inflammation in cortical multiple sclerosis lesions. Ann Neurol. 2001 ; 50: 389-400
19. Fünfschilling U, Supplie LM, Mahad D, et al. Glycolytic oligodendrocytes maintain myelin and long-term axonal integrity. Nature. 2012 ; 485: 517-521
20. Lee Y, Morrison BM, Li Y, et al. Oligodendroglia metabolically support axons and contribute to neurodegeneration. Nature. 2012 ; 487: 443-448
21. Smith KJ.. Sodium channels and multiple sclerosis: Roles in symptom production, damage and therapy. Brain Pathol. 2007 ; 17: 230-242
22. Kiryu-Seo S, Ohno N, Kidd GJ, et al. Demyelination increases axonal stationary mitochondrial size and the speed of axonal mitochondrial transport. J Neurosci. 2010 ; 30: 6658-6666
23. Mahad DJ, Ziabreva I, Campbell G, et al. Mitochondrial changes within axons in multiple sclerosis. Brain. 2009 ; 132: 1161-1174
24. Hogan V, White K, Edgar J, et al. Increase in mitochondrial density within axons and supporting cells in response to demyelination in the Plp1 mouse model. J Neurosci Res. 2009 ; 87: 452-459
25. Smith CM, Cooksey E, Duncan ID.. Myelin loss does not lead to axonal degeneration in a long-lived model of chronic demyelination. J Neurosci. 2013 ; 33: 2718-2727
26. Zambonin JL, Zhao C, Ohno N, et al. Increased mitochondrial content in remyelinated axons: Implications for multiple sclerosis. Brain. 2011 ; 134: 1901-1913
27. Mitochondria as a central sensor for axonal degenerative stimuli. Trends Neurosci. 2012 ; 35: 364-372
28. MacAskill AF, Kittler JT.. Control of mitochondrial transport and localization in neurons. Trends Cell Biol. 2010 ; 20: 102-112
29. Kang JS, Tian JH, Pan PY, et al. Docking of axonal mitochondria by syntaphilin controls their mobility and affects short-term facilitation. Cell. 2008 ; 132: 137-148
30. Ohno N, Kidd GJ, Mahad D, et al. Myelination and axonal electrical activity modulate the distribution and motility of mitochondria at CNS nodes of Ranvier. J Neurosci. 2011 ; 31: 7249-7258
31. Broadwater L, Pandit A, Clements R, et al. Analysis of the mitochondrial proteome in multiple sclerosis cortex. Biochimica Biophys Acta. 2011 ; 1812: 630-641
32. Campbell GR, Ziabreva I, Reeve AK, et al. Mitochondrial DNA deletions and neurodegeneration in multiple sclerosis. Ann Neurol. 2011 ; 69: 481-492
33. Dutta R, McDonough J, Yin X, et al. Mitochondrial dysfunction as a cause of axonal degeneration in multiple sclerosis patients. Ann Neurol. 2006 ; 59: 478-489
34. Witte ME, Nijland PG, Drexhage JA, et al. Reduced expression of PGC-1alpha partly underlies mitochondrial changes and correlates with neuronal loss in multiple sclerosis cortex. Acta Neuropathol. 2013 ; 125: 231-243
35. Larsson NG.. Somatic mitochondrial DNA mutations in mammalian aging. Annu Rev Biochem. 2010 ; 79: 683-706
36. Fischer MT, Sharma R, Lim JL, et al. NADPH oxidase expression in active multiple sclerosis lesions in relation to oxidative tissue damage and mitochondrial injury. Brain. 2012 ; 135: 886-899
37. Howell OW, Reeves CA, Nicholas R, et al. Meningeal inflammation is widespread and linked to cortical pathology in multiple sclerosis. Brain. 2011 ; 134: 2755-2771
38. Magliozzi R, Howell OW, Reeves C, et al. A gradient of neuronal loss and meningeal inflammation in multiple sclerosis. Ann Neurol. 2010 ; 68: 477-493
39. Campbell GR, Kraytsberg Y, Krishnan KJ, et al. Clonally expanded mitochondrial DNA deletions within the choroid plexus in multiple sclerosis. Acta Neuropathol. 2012 ; 124: 209-220
40. Kraytsberg Y, Kudryavtseva E, McKee AC, et al. Mitochondrial DNA deletions are abundant and cause functional impairment in aged human substantia nigra neurons. Nat Genet. 2006 ; 38: 518-520
41. Witte ME, Mahad DJ, Lassmann H, et al. Mitochondrial dysfunction contributes to neurodegeneration in multiple sclerosis. Trends Mol Med. 2014 ; 20: 179-187
42. Nikiė I, Merkler D, Sorbara C, et al. A reversible form of axon damage in experimental autoimmune encephalomyelitis and multiple sclerosis. Nat Med. 2011 ; 17: 495-499
43. Qi X, Lewin AS, Sun L, et al. Mitochondrial protein nitration primes neurodegeneration in experimental autoimmune encephalomyelitis. J Biol Chem. 2006 ; 281: 31950-31962
44. Mahad D, Ziabreva I, Lassmann H, et al. Mitochondrial defects in acute multiple sclerosis lesions. Brain. 2008 ; 131: 1722-1735
45. Edgar JM, McCulloch MC, Montague P, et al. Demyelination and axonal preservation in a transgenic mouse model of Pelizaeus-Merzbacher disease. EMBO Mol Med. 2010 ; 2: 42-50
46. Hares K, Kemp K, Rice C, et al. Reduced axonal motor protein expression in non-lesional grey matter in multiple sclerosis. Mult Scler. 2013 ;:
47. Kim JY, Shen S, Dietz K, et al. HDAC1 nuclear export induced by pathological conditions is essential for the onset of axonal damage. Nat Neurosci. 2010 ; 13: 180-189
48. Sterky FH, Lee S, Wibom R, et al. Impaired mitochondrial transport and Parkin-independent degeneration of respiratory chain-deficient dopamine neurons in vivo. Proc Natl Acad Sci U S A. 2011 ; 108: 12937-12942
49. Pinto M, Moraes CT.. Mitochondrial genome changes and neurodegenerative diseases. Biochim Biophys Acta. 2014 ; 1842: 1198-1207
50. Schuh C, Wimmer I, Hametner S, et al. Oxidative tissue injury in multiple sclerosis is only partly reflected in experimental disease models. Acta Neuropathol. 2014 ;:
51. DeLuca GC, Ebers GC, Esiri MM.. Axonal loss in multiple sclerosis: A pathological survey of the corticospinal and sensory tracts. Brain. 2004 ; 127: 1009-1018